Can Huntington's disease clinical trial design tweaks lead to success?

After a series of disappointing clinical trial data in Huntington’s disease, study design changes take aim at moving the field forward.

Related Keywords

Canada ,Neurocrine Biosciences ,Prilenia Hayden ,Annexon Biosciences ,Prelinia Hayden ,Christopher Ross ,Lundbeck Xenazine ,Michael Hayden ,Wave Life Sciences ,Prilenia Therapeutics ,Annexon Bioscience ,Unified Huntington ,Disease Rating Scale ,Total Functional Capacity ,John Hopkins ,Total Motor Score ,Although Wave ,Total Maximal Chorea ,Teva Pharmaceutical ,Regulatory Consultation ,Preference Management Solution ,